Abstract
In mitochondrial apoptosis, the formation of cytochrome c-cardiolipin complex ([CL-cyt c]) with peroxidase properties is an early event in the cascade of reactions that leads to cell death. Herein, we report the synthesis of a new prodrug, (2-hydroxyamino-vinyl)-triphenyl-phosphonium (HVTP), which compartmentalizes exclusively into mitochondria, undergoes a [CL-cyt c]-catalyzed bioactivation to nitric oxide (NO), inhibits peroxidase activity, and protects cells from apoptosis.
Publication types
-
Research Support, N.I.H., Extramural
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Animals
-
Apoptosis* / drug effects
-
Caspase 3 / metabolism
-
Caspase 7 / metabolism
-
Catalysis / drug effects
-
Cell Compartmentation
-
Cytochromes c / metabolism*
-
Cytoprotection / drug effects
-
Dactinomycin / pharmacology
-
Enzyme Activation / drug effects
-
Hydroxylamines / metabolism*
-
Hydroxylamines / pharmacology
-
Mice
-
Mitochondria / drug effects
-
Mitochondria / enzymology*
-
Nitric Oxide / metabolism*
-
Nitric Oxide Donors / metabolism*
-
Organophosphorus Compounds / metabolism*
-
Organophosphorus Compounds / pharmacology
-
Oxidation-Reduction / drug effects
-
Peroxidases / antagonists & inhibitors
-
Peroxidases / metabolism*
-
Phosphatidylserines / metabolism
Substances
-
(2-hydroxyaminovinyl)triphenylphosphonium
-
Hydroxylamines
-
Nitric Oxide Donors
-
Organophosphorus Compounds
-
Phosphatidylserines
-
Dactinomycin
-
Nitric Oxide
-
Cytochromes c
-
Peroxidases
-
Caspase 3
-
Caspase 7